Galovan Scott Michael 4

What Happened

• Scott Galovan, Chief Financial Officer of Avanos Medical (AVNS), surrendered 1,119 shares to the company to satisfy tax withholding obligations tied to the vesting of restricted share units. The shares were valued at $13.29 each, for a total of approximately $14,872. The underlying award comprised 3,235 time-based restricted share units (TRSUs) that vested on March 9, 2026; after withholding, 2,116 net shares were issued to him.

Key Details

• Transaction date: March 9, 2026
• Price per share: $13.29; Shares surrendered: 1,119; Reported proceeds/consideration: $14,872 (rounded)
• Award/vesting: 3,235 TRSUs awarded March 7, 2025 and vested March 9, 2026; each TRSU = 1 share
• Net shares delivered to insider after withholding: 2,116 (3,235 vested − 1,119 withheld)
• Transaction code: F (shares surrendered for tax withholding)
• Filing date/accession: Form filed March 11, 2026 (timely; within standard Form 4 reporting window)
• Shares owned after transaction: not specified in the provided filing excerpt

Context

• This was a routine tax-withholding share surrender tied to the vesting of equity awards (a common administrative action), not an open-market sale or purchase. Such withholding transactions are administrative and generally do not signal a change in the insider’s investment view.